Europe small molecule API market was valued at $43.5 billion in 2022 and will grow by 7.4% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.
Highlighted with 70 tables and 52 figures, this 132-page report "Europe Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire Europe small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Country.
Based on Source, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Semi-synthetic API
• Natural Origin
Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Standard API
• High Potency API (HPAPI)
o Branded HPAPI
o Generic HPAPI
By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Clinical Use
• Commercial Use
By Manufacturer Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pharmaceutical Companies
• CMOs
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 26
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter's Fiver Forces Analysis 41
3 Segmentation of Europe Market by Source 45
3.1 Market Overview by Source 45
3.2 Synthetic API 47
3.2.1 Branded Synthetic API 48
3.2.2 Generic Synthetic API 49
3.3 Semi-synthetic API 50
3.4 Natural Origin 51
4 Segmentation of Europe Market by Product Type 52
4.1 Market Overview by Product Type 52
4.2 Standard API 54
4.3 High Potency API (HPAPI) 55
4.3.1 Branded HPAPI 56
4.3.2 Generic HPAPI 57
5 Segmentation of Europe Market by Therapeutic Area 58
5.1 Market Overview by Therapeutic Area 58
5.2 Infectious Diseases 60
5.3 Oncology 61
5.4 Ophthalmology 62
5.5 Cardiovascular Disorders 63
5.6 Central Nervous System 64
5.7 Respiratory Disorders 65
5.8 Metabolic Diseases 66
5.9 Other Therapeutic Areas 67
6 Segmentation of Europe Market by Application 68
6.1 Market Overview by Application 68
6.2 Clinical Use 70
6.3 Commercial Use 71
7 Segmentation of Europe Market by Manufacturer Type 72
7.1 Market Overview by Manufacturer Type 72
7.2 Pharmaceutical Companies 74
7.3 CMOs 76
8 European Market 2022-2032 by Country 78
8.1 Overview of European Market 78
8.2 Germany 81
8.3 U.K. 83
8.4 France 85
8.5 Spain 87
8.6 Italy 89
8.7 Russia 91
8.8 Rest of European Market 93
9 Competitive Landscape 95
9.1 Overview of Key Vendors 95
9.2 New Product Launch, Partnership, Investment, and M&A 98
9.3 Company Profiles 99
Aurobindo Pharma Ltd. 99
Cambrex Corporation 101
Catalent Inc. 102
Dr. Reddy's Laboratories 105
GlaxoSmithKline plc 108
Lonza Group 112
Merck & Co., Inc. 115
Mylan N.V. 117
Novartis AG 119
Pfizer Inc. 121
Sun Pharmaceutical Industries Ltd. 125
Teva Pharmaceutical Industries Ltd. 128
Wuxi AppTec Co., Ltd. 130
RELATED REPORTS 132
The Small Molecule Drug Design Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Small Business Payroll Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
Market Overview
The Europe Vanadium Market is poised for significant growth from 2024 to 2034, driven by increasing demand across diverse industries such as iron and steel production, energy storage, and chemicals. The market is expected to reach USD XX.XX billion by 2034, expanding at ...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The Europe Anti-Pollution Mask Market is anticipated to witness significant growth from 2024 to 2034, driven by rising awareness of air pollution's health impacts and the increasing adoption of protective measures. The market is projected to reach a valuation of USD XX.X...
Market Overview
The Europe Ethnic Wear Market is expected to experience robust growth from 2024 to 2034, fueled by a growing appreciation for traditional and culturally significant apparel, alongside a rising inclination towards fusion wear. The market is projected to attain a valuation...
Market Overview
The Europe FinTech Investment Market is poised for significant expansion from 2024 to 2034, driven by rapid technological advancements, evolving consumer preferences, and the increasing integration of digital finance solutions. The market is expected to reach a valuation...
Market Overview
The Europe Airport Asset Tracking Market is set for substantial growth between 2024 and 2034, fueled by the increasing need for efficient asset management across airports to enhance operational efficiency and minimize asset loss or misplacement. The market is projected t...
Market Overview
The Europe Sustainable Aviation Fuel Market is poised for significant growth from 2024 to 2034, driven by escalating environmental concerns and regulatory pressures to reduce carbon emissions in the aviation sector. The market is projected to reach USD XX.XX billion by 2...